Meaningful Data Drives Better Trial Design and Faster Drug Approvals

But data for rare diseases can be difficult to obtain, which is why patient registries are playing an increasingly important role in helping bridge the data gap.

By Ashley Winslow, Ph.D.

October 25, 2017

Patient Registry GrraphicThe University of Pennsylvania Orphan Disease Center’s (ODC) international patient registry is a collection of information about individuals focused around a specific diagnosis or condition. The registry’s goal is to generate better data, which can result in better trial design, quicker recruitment of patients and faster approvals of new drugs.
Continue reading


Living with Hereditary Angioedema Can Be Frightening

Hereditary angioedema (HAE) is a rare genetic disease caused by a deficiency or dysfunction of a protein called C1 esterase inhibitor. HAE can cause swelling in certain parts of the body, such as the stomach, hands, and face, which can be painful and, in some cases, life threatening.

August 31st, 2017

Margaret Mary Conger, a member of CSL Behring’s Patient Engagement and Reimbursement team, recently sat down with Tad Rockwell, hereditary angioedema patient, clinical trial participant and passionate advocate, who spoke candidly about his long and scary road to diagnosis and treatment.

Tad Rockwell, who battled hereditary angioedema since he was a child, enjoys making breakfast for his family.

Continue reading


Putting Patients First: Why We Partner with Advocacy Groups

By Dr. Lutz Bonacker

August 24, 2017

At CSL Behring we have been working collaboratively with patient organizations for years, informed by our core value that patients come first. Our CEO Paul Perreault puts it this way: “If you take care of the patients, the business takes care of itself.” It has also been our experience that the sole commitment of every patient group with which we collaborate is to the health and well-being of their members.

Continue reading


Novel Ways of Using Immunoglobulin to Treat Disabling Neurological Disorders Are Being Explored

Researchers are targeting autoimmune epilepsy and chronic inflammatory demyelinating polyneuropathy.

By Karen MacPhail and Gabriela Espinoza, MD

July 25, 2017

As many as one billion people worldwide suffer from more than 600 neurological disorders, according to the World Health Organization and University of California, San Francisco, respectively. Of that number, it is estimated that 6.8 million people die each year from neurological disorders ranging from epilepsy to Alzheimer’s disease.

Neurological disorders affect the central nervous systems or the peripheral nervous systems and can impair the brain, spinal cord, peripheral nerve or neuromuscular function.

Continue reading

Posts represent the opinion of the author and do not necessarily reflect the views of CSL Behring.
This site is not intended as a forum for discussing CSL Behring or other companies' products.
Comments on this blog may be reviewed by CSL Behring and may be subject to removal if they are deemed to have inappropriate content.